The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cells
- 5 April 2005
- journal article
- Published by Wiley in Immunology
- Vol. 115 (2) , 170-178
- https://doi.org/10.1111/j.1365-2567.2005.02145.x
Abstract
Summary: Accumulating evidence indicates that the CD4 homologue lymphocyte activation gene‐3 (LAG‐3) plays a down‐regulatory role on T‐cell responses. However, the role of LAG‐3/major histocompatibility complex (MHC) class II interactions on primary human T‐cell responses, as well as the mechanism by which down‐regulation occurs, are not clear. Here, we show that LAG‐3 colocalized with CD3, CD4 or CD8 in areas of cholesterol‐rich raft aggregation during this primary response, as well as in the clustered raft region formed between T cells and antibody‐coated beads. Addition of a blocking LAG‐3‐specific monoclonal antibody to both CD4 and CD8 primary resting T cells activated under conditions of antigen‐presenting cell‐driven stimulation and low antigen concentrations augments CD69 activation antigen expression, T‐cell expansion and T helper 1 (Th1, but not Th2) cytokine production. Blocking LAG‐3/MHC class II interactions leads to an increase in the number of cells entering division at these low concentrations of antigen and to more rounds of divisions with an accumulation of cells in the S‐phase of the cell cycle. These results indicate that LAG‐3 signalling inhibits early events in primary activation of human CD4 and CD8 T cells and further support a role for LAG‐3 signalling in regulating the expansion of activated effector or memory T cells, either directly or indirectly through Treg suppressor activity.Keywords
This publication has 30 references indexed in Scilit:
- Role of LAG-3 in Regulatory T CellsPublished by Elsevier ,2004
- MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223)Blood, 2003
- The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cellsEuropean Journal of Immunology, 2003
- CTLA-4: new insights into its biological function and use in tumor immunotherapyNature Immunology, 2002
- Surface Cytotoxic T Lymphocyte–associated Antigen 4 Partitions Within Lipid Rafts and Relocates to the Immunological Synapse under Conditions of Inhibition of T Cell ActivationThe Journal of Experimental Medicine, 2002
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.The Journal of Experimental Medicine, 1996
- CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteinsEuropean Journal of Immunology, 1995
- Lymphocyte‐activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytesEuropean Journal of Immunology, 1994
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- LAG-3, a novel lymphocyte activation gene closely related to CD4.The Journal of Experimental Medicine, 1990